Mine gains knowledge with each new CoreX Assay run and each AlloChem compound tested.
Mine employs the leading open system data analysis platforms to implement AI/Machine Learning to gain deeper insights into our experimental data. The purpose is not computation in place of experimentation, but rather experimentation augmented by computation.
Mine is implemented using the industry’s most advanced computing frameworks bringing AI/ML methods to bear on drug discovery data analysis. These tools allow us to discover drugs where traditional methods fail.
This triad of biology (CoreX), chemistry (AlloChem) and computational technologies (Mine) gives Sharp unique capabilities, significantly increasing the chances of delivering successful drug candidates for the treatment of genetic disorders.
To see how we’re applying the technology, visit our
Pipeline page.
